Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_provenance.
- NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_assertion description "[According to the LOH study at intragenic polymorphic sites, deletion of Bcl10 in informative cases was detected in 50% of malignant mesotheliomas, 33% of gastric carcinomas, 23% of breast carcinomas, 20% of hepatocellular carcinomas, 17% of lymphomas, 15% of colorectal carcinomas, 13% of laryngeal carcinomas, and 10% of male germ cell tumors (GCTs).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_provenance.
- NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_assertion evidence source_evidence_literature NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_provenance.
- NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_assertion SIO_000772 10582682 NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_provenance.
- NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_assertion wasDerivedFrom befree-20150227 NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_provenance.
- NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_assertion wasGeneratedBy ECO_0000203 NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_provenance.
- befree-20150227 importedOn "2015-02-27" NP811168.RAngytKorlteBF4DUF3_wVa3YcfWcG6hhtApfz_HKAwas130_provenance.